THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER

QR Code

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER

The role of the level of prostate specific antigen ( PSA) before initial therapy discusses widely as a prognostic factor in the treatment of prostate cancer (PC ). Despite the fact that many of the questions on the diagnostic and prognostic value of PSA unclear, and new markers of prostate dis...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Gritskevich, V. L. Medvedev, S. V. Mishugin, N. A. Apolskaya, I. G. Rusakov
Format:	Article
Language:	English
Published:	Bashkir State Medical University 2017-02-01
Series:	Креативная хирургия и онкология
Subjects:	prostate-specific antigen gleason score prostate cancer
Online Access:	https://www.surgonco.ru/jour/article/view/169
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PSA AND ITS RELATION TOTHE DEGREE OF DIFFERENTIATION OF PROSTATE CANCER
by: B. Lazarov
Published: (2025-03-01)

The relationship between methylation of tumor suppressor genes <i>APC</i>, <i>GSTP1</i>, <i>RASSF1A</i> and content of prostate-specific antigen- associated markers in prostate cancer diagnosis
by: I. A. Aboyan, et al.
Published: (2023-10-01)

Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
by: Gao X, et al.
Published: (2025-06-01)

Delayed diagnosis of prostate cancer in a patient with low PSA levels following prior TURP surgery: A case report
by: Tianchi Hua, et al.
Published: (2025-07-01)

Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP Study
by: Martin Wallisch, et al.
Published: (2025-08-01)

OPTIMIZATION OF PRIMARY TRANSRECTAL MULTIFOCAL PROSTATE BIOPSY USING PERFUSION COMPUTED TOMOGRAPHY
by: N. V. Sosnovskiy, et al.
Published: (2018-11-01)

Consistency between Gleason score of prostate biopsy and radical prostatectomy: predictors of increased tumour grading
by: O. Yu. Nesterova, et al.
Published: (2024-09-01)

Detection of prostate cancer in the PSA gray zone using prostate-specific antigen mass ratio combined with PI-RADS score
by: Weilin Li, et al.
Published: (2025-07-01)

Using 320-slice perfusion computed tomography in visuali zation of prostate cancer
by: N. V. Sosnowski, et al.
Published: (2016-12-01)

The Effect of Fructose Level and Prostate Specific Antigen (PSA) on Sperms Motility in InFertiled Men
by: Aiesha saadoun jassim, et al.
Published: (2023-01-01)

Unique Biological Characteristics of Patients with High Gleason Score and Localized/Locally Advanced Prostate Cancer Using an In Silico Translational Approach
by: Shiori Miyachi, et al.
Published: (2025-07-01)

Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden
by: Innocent B. Mboya, et al.
Published: (2025-06-01)

Design of a Novel Electrochemical Nanobiosensor for the Detection of Prostate Cancer by Measurement of PSA Using Graphene-based Materials
by: Fatemeh Saeidi tabar, et al.
Published: (2021-12-01)

PSA density as a predictor of long-term infectious complications during transurethral resection of the prostate: determining an optimal cut-off value
by: S. N. Ivanov, et al.
Published: (2024-03-01)

Prostate cancer in men under 50: the impact of race/ethnicity and family history
by: Lechuang Chen, et al.
Published: (2025-12-01)

Microsatellite Instability and BAT-26 Marker Expression in a Mexican Prostate Cancer Population with Different Gleason Scores
by: Ana K. Flores-Islas, et al.
Published: (2025-06-01)

Single-Center Experience in Targeted Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging‑Transrectal Ultrasound Elastic Fusion Technique
by: Jennifer Farah, et al.
Published: (2020-07-01)

PI-RADSv2.1 combined with PSA density for optimizing prostate biopsy decisions: a retrospective analysis
by: Yuchun Li, et al.
Published: (2025-07-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Non-invasive electromagnetic detection of prostate cancer: efficiency analysis
by: M. E. Chaliy, et al.
Published: (2023-04-01)

Use of immunohistochemical markers in clinical-morphological diagnostic of prostate diseases
by: Grygorieva J. V.
Published: (2010-01-01)

Relationship between serum Prostate Specific Antigen (PSA) in women with polycystic ovary syndrome and some reproductive hormones in Kirkuk city
by: Marwa Ghazi Rifatt, et al.
Published: (2023-02-01)

Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
by: Patricia Tai, et al.
Published: (2025-07-01)

Prostate specific antigen density as a prognostic factor in patients with prostate cancer treated with combined hormonal radiation therapy
by: A. Y. Kneev, et al.
Published: (2022-06-01)

Effectiveness of hormone therapy in patients with prostate cancer. Regional experience
by: P. G. Berezin, et al.
Published: (2020-12-01)

LU-177-PSMA TREATMENT FOR METASTATIC PROSTATE CANCER – CASE EXAMPLES OF MIRACLE RESPONSES
by: K. Kairemo, et al.
Published: (2018-03-01)

CLINICAL SIGNIFICANSE OF PROSTATE-SPECIFIC ANTIGEN IN BREAST CANCER PATIENTS
by: N. S. Sergeeva, et al.
Published: (2020-12-01)

Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer
by: L. V. Spirina, et al.
Published: (2019-04-01)

Ascite-solid model of prostate cancer and its morphological characteristics
by: E. A. Plotnikova, et al.
Published: (2023-09-01)

PROSTATE CANCER WITH A HIGH BASELINE PSA LEVEL AFTER COMBINED TREATMENT
by: A. T. Asratov, et al.
Published: (2017-12-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Immunosensor Enhanced with Silver Nanocrystals for On-Chip Prostate-Specific Antigen Detection
by: Timothy A. Okhai, et al.
Published: (2025-07-01)

Estimation of Testosterone, Estradiol and some Markers in Sera of Iraqi Patients with Benign Prostatic Hyperplasia.
by: Baghdad Science Journal
Published: (2013-12-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

MOLECULAR IMAGING AND INTRAOPERATIVE RADIONAVIGATION IN PROSTATE CANCER
by: P. O. Rumyantsev, et al.
Published: (2021-08-01)

USE OF <sup>177</sup>Lu-PSMA FOR RADIONUCLIDE THERAPY IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER
by: A. A. Medvedeva, et al.
Published: (2021-06-01)

Unfavorable low-risk factors predict pathologic upstaging and upgrading following radical prostatectomy: Evidence for further subclassification of low-risk prostate cancer?
by: Magdelinić Aleksandar, et al.
Published: (2025-01-01)

Robot-Assisted Radical Prostatectomy in High-Risk Prostate Cancer
by: V. N. Pavlov, et al.
Published: (2021-12-01)

MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
by: Z. M. Akhokhov, et al.
Published: (2023-10-01)